Silvia Muro

Institució Catalana de Recerca i Estudis Avançats — Spain

Materials Science · Physical Sciences

44h-index5.9kcitations127works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(39), Lysosomal Storage Disorders Research(25), Cell Adhesion Molecules Research(22), RNA Interference and Gene Delivery(19), Cellular transport and secretion(16)

Publications126 total

ICAM-1 targeting of nanocarriers in a human blood-brain-barrier-on-a-chip complements <i>in vivo</i> brain delivery observations
Journal of drug targeting·2025
Presence of ICAM-1 isoforms in human cells impacts the selection of antibodies for nanocarrier targeting
Journal of Drug Delivery Science and Technology·2024
Isoform-specific vs. isoform-universal drug targeting: a new targeting paradigm illustrated by new anti-ICAM-1 antibodies
Journal of drug targeting·2024· 3 cited
New cellular models to support preclinical studies on ICAM-1-targeted drug delivery
Journal of Drug Delivery Science and Technology·2024· 4 citedOpen Access
Lysosomal therapies and drug delivery strategies: An overview
Advanced Drug Delivery Reviews·2023· 4 cited
Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders
Journal of Functional Biomaterials·2023· 7 citedOpen Access
Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain
ACS Nano·2023· 28 citedOpen Access
Effect of acid sphingomyelinase deficiency in type A Niemann-Pick disease on the transport of therapeutic nanocarriers across the blood–brain barrier
Drug Delivery and Translational Research·2023· 3 cited
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders
Advanced Drug Delivery Reviews·2023· 25 citedOpen Access
Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases
Journal of Controlled Release·2022· 18 citedOpen Access
Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type
Pharmaceutics·2022· 5 citedOpen Access
Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy
International Journal of Molecular Sciences·2022· 18 citedOpen Access
Targeted nanocarriers coopting pulmonary leukocytes for drug delivery to the injured brain
2022· 3 citedOpen Access
Drug Delivery Systems: A Few Examples of Applications, Drug Cargoes, and Administration Routes
Current Pharmaceutical Design·2021Open Access
Engineering subtilisin proteases that specifically degrade active RAS
Communications Biology·2021· 18 citedOpen Access
Intracellular Delivery of Active Proteins by Polyphosphazene Polymers
Pharmaceutics·2021· 12 citedOpen Access
A method to improve quantitative <scp>radiotracing‐based</scp> analysis of the in vivo biodistribution of drug carriers
Bioengineering & Translational Medicine·2020· 5 citedOpen Access
Engineering protein-specific proteases: targeting active RAS
2020· 1 citedOpen Access
Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme
Journal of Controlled Release·2020· 24 citedOpen Access
δ-Tocopherol Effect on Endocytosis and Its Combination with Enzyme Replacement Therapy for Lysosomal Disorders: A New Type of Drug Interaction?
Journal of Pharmacology and Experimental Therapeutics·2019· 6 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Vladimir R. Muzykantov(24), Carmen Garnacho(10), Tridib Kumar Bhowmick(7), Edward H. Schuchman(6), Michael Koval(6), Vladimir V. Shuvaev(6), Janet Hsu(5), John Leferovich(4), Christine Gajewski(4), Steven Μ. Albelda(4), Melpo Christofidou‐Solomidou(4), Melani Solomon(4), Magdalena Ugarte(4), Pilar Rodríguez‐Pombo(4), Eva Richard(4), Thomas D. Dziubla(3), Xiumin Cui(3), Rasa Ghaffarian(3), Eric Simone(3), Lourdes R. Desviat(3)